NAPWA

The Australian HIV Observational Database (AHOD) is an important monitor of trends in an iretroviral patterns and emerging health issues within the HIV community. read more »

HIV Futures is a national survey of Australian people living with HIV conducted every two years by the Living with HIV program at the Australian Research Centre in Sex, Health and Society at La Trobe University.

It is an anonymous survey asking important questions about the health, treatments, work and financial situations of people with HIV in Australia. read more »

At the conference, Julian Elliot from The Burnet Institute in Melbourne spoke of our ‘combo-prevention future’, where a successful vaccine and cure could potentially end the epidemic. read more »

Aside from making people feel terrible when they drink, a drug used for years to treat alcoholism, Antabuse, apparently also has the ability to activate immune cells.

Whether it can activate latently infected cells and make them vulnerable to HIV treatment and the immune system is not yet known, but that is what a small US study seeks to understand. read more »

While it has long been acknowledged that successful antiretroviralA medication or other substance which is active against retroviruses such as HIV. treatment and an undetectable viral loadA measurement of the quantity of HIV RNA in the blood. Viral load blood test results are expressed as the number of copies (of HIV) per milliliter of blood plasma. lowers the risk of passing on HIV, we have little research to support the fact. read more »

HIV futures six: Making positive lives count, a national survey of the health and wellbeing of HIV positive people, has been published.

Produced by the Living with HIV Program, part of The Australian Research Centre in Sex, Health and Society at La Trobe University, it can be viewed at the HIV Futures website: www.latrobe.edu.au/hivfutures read more »

PRO 2000, the microbicide gel, has failed to protect women against HIV infection in the largest microbicide study to date. read more »

Why would anyone choose to specialise in HIV medicine? And what possible incentives are there to make you stay? These are questions you may well have contemplated while sitting in your own doctor’s waiting room. read more »

The Conference on Retroviruses and Opportunistic Infections (CROI) has just happened in San Francisco. This meeting is held annually and focuses on the very latest in basic science and clinicalPertaining to or founded on observation and treatment of participants, as distinguished from theoretical or basic science. research. Jo Watson was there and gives us an overview. read more »

A treatment regimen consisting of one nonnucleoside (1NNRTI) and two nucleosides (2NRTIs) has become the internationally accepted first-line therapy of choice. But effective as the combination is, it doesn’t work for everyone. And those it fails need a reliable back-up. read more »